magnolol has been researched along with glycyrrhetinic acid in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chang, ST; Chien, SC; Hou, CC; Hsiao, PW; Jan, JT; Kuo, CJ; Kuo, YH; Lee, CK; Lee, SS; Liang, PH; Liu, HG; Shyur, LF; Wang, SY; Wen, CC; Yang, NS | 1 |
| Batista-Gonzalez, A; Brunhofer, G; Fallarero, A; Gopi Mohan, C; Karlsson, D; Shinde, P; Vuorela, P | 1 |
2 other study(ies) available for magnolol and glycyrrhetinic acid
| Article | Year |
|---|---|
Specific plant terpenoids and lignoids possess potent antiviral activities against severe acute respiratory syndrome coronavirus.
Topics: Animals; Betulinic Acid; Cell Proliferation; Chlorocebus aethiops; Coronavirus 3C Proteases; Cysteine Endopeptidases; Lignans; Models, Molecular; Pentacyclic Triterpenes; Plants, Medicinal; Severe acute respiratory syndrome-related coronavirus; Structure-Activity Relationship; Terpenes; Triterpenes; Vero Cells; Viral Proteins; Virus Replication | 2007 |
Exploration of natural compounds as sources of new bifunctional scaffolds targeting cholinesterases and beta amyloid aggregation: the case of chelerythrine.
Topics: Acetylcholinesterase; Amyloid beta-Peptides; Benzophenanthridines; Binding Sites; Butyrylcholinesterase; Catalytic Domain; Cholinesterase Inhibitors; Humans; Isoquinolines; Kinetics; Molecular Docking Simulation; Structure-Activity Relationship | 2012 |